XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Disaggregation of Total Revenues

The following table disaggregates total revenues from external customers by product sales, royalty revenue, and collaboration and license revenue (in thousands):

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2024

 

 

2023

 

2024

 

 

2023

 

Product sales:

 

 

 

 

 

 

 

 

 

 

Crysvita

$

35,604

 

 

$

19,200

 

$

112,294

 

 

$

57,318

 

Dojolvi

 

21,374

 

 

 

16,553

 

 

57,091

 

 

 

47,347

 

Mepsevii

 

9,616

 

 

 

5,633

 

 

22,372

 

 

 

22,552

 

Evkeeza

 

10,657

 

 

 

963

 

 

21,788

 

 

 

1,540

 

Total product sales

 

77,251

 

 

 

42,349

 

 

213,545

 

 

 

128,757

 

Crysvita royalty revenue

 

62,243

 

 

 

55,703

 

 

181,808

 

 

 

106,916

 

Collaboration and license revenue:

 

 

 

 

 

 

 

 

 

 

Crysvita collaboration revenue in Profit-
    Share Territory

 

 

 

 

 

 

 

 

 

69,705

 

Daiichi Sankyo

 

 

 

 

 

 

 

 

 

1,479

 

Total collaboration and license revenue

 

 

 

 

 

 

 

 

 

71,184

 

Total revenues

$

139,494

 

 

$

98,052

 

$

395,353

 

 

$

306,857

 

The following table disaggregates total revenues based on geographic location (in thousands):

 

Three Months Ended

 

Nine Months Ended

 

 

September 30,

 

September 30,

 

 

2024

 

 

2023

 

2024

 

 

2023

 

North America

$

76,914

 

 

$

67,811

 

$

223,485

 

 

$

214,232

 

Latin America

 

38,048

 

 

 

17,229

 

 

112,155

 

 

 

59,096

 

Europe, Middle East, and Africa

 

22,222

 

 

 

13,012

 

 

54,352

 

 

 

32,351

 

Asia-Pacific

 

2,310

 

 

 

 

 

5,361

 

 

 

1,178

 

Total revenues

$

139,494

 

 

$

98,052

 

$

395,353

 

 

$

306,857